Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Announces Two More Medical Device Consent Decrees

This article was originally published in The Gray Sheet

Executive Summary

FDA has already completed three consent decrees blocking sales of medical devices in 2007, with two surfacing last week. The agency has not obtained more than two device-related injunctions in any of the previous six years
Advertisement

Related Content

Facilities Must Stop Using Custom Ultrasonics' System To Reprocess Duodenoscopes, FDA Warns
CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction
Cardinal Health inks amended consent decree with FDA
Cardinal’s Latest Infusion Pump Recall Could Take Months To Resolve
FDA Seizes Tissue Valve Firm’s Entire Product Line, Citing Sterilization Issues
Baxter Clears Hurdle On Road To Resuming Infusion Pump Sales
FDA Consent Decree Bars Sales Of GE X-Ray Systems
FDA Consent Decree Bars Sales Of GE X-Ray Systems
Cardinal Health Is Second Infusion Pump Maker To Be Hit By An FDA Seizure
Baxter’s Colleague Consent Decree Enjoins Sales, Expands Obligations
Advertisement
UsernamePublicRestriction

Register

MT024483

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel